These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29274774)

  • 1. Nanotherapy for Alzheimer's disease and vascular dementia: Targeting senile endothelium.
    D'Arrigo JS
    Adv Colloid Interface Sci; 2018 Jan; 251():44-54. PubMed ID: 29274774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Early Dementia: Using Lipid Cubic Phase Nanocarriers to Cross the Blood⁻Brain Barrier.
    D'Arrigo JS
    Biomimetics (Basel); 2018 Mar; 3(1):. PubMed ID: 31105226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between Alzheimer's disease and vascular dementia: implications for treatment.
    Kalaria RN
    Neurol Res; 2003 Sep; 25(6):661-4. PubMed ID: 14503021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrovascular hemodynamics in Alzheimer's disease and vascular dementia: a meta-analysis of transcranial Doppler studies.
    Sabayan B; Jansen S; Oleksik AM; van Osch MJ; van Buchem MA; van Vliet P; de Craen AJ; Westendorp RG
    Ageing Res Rev; 2012 Apr; 11(2):271-7. PubMed ID: 22226802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy.
    Bär KJ; Boettger MK; Seidler N; Mentzel HJ; Terborg C; Sauer H
    Stroke; 2007 Dec; 38(12):3186-92. PubMed ID: 17962592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum autoantibodies in patients with Alzheimer's disease and vascular dementia and in nondemented control subjects.
    Lopez OL; Rabin BS; Huff FJ; Rezek D; Reinmuth OM
    Stroke; 1992 Aug; 23(8):1078-83. PubMed ID: 1636181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system neurodegeneration and tinnitus: a clinical experience. Part II: translational neurovascular theory of neurodegenerative CNS disease and tinnitus.
    Shulman A; Goldstein B; Strashun AM
    Int Tinnitus J; 2008; 14(1):43-51. PubMed ID: 18616086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic Nanocarrier Targeting Drug(s) to Upstream-Receptor Mechanisms in Dementia: Focusing on Linking Pathogenic Cascades.
    D'Arrigo JS
    Biomimetics (Basel); 2020 Mar; 5(1):. PubMed ID: 32244941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial and extracranial ultrasound assessment of cerebral hemodynamics in vascular and Alzheimer's dementia.
    Doepp F; Valdueza JM; Schreiber SJ
    Neurol Res; 2006 Sep; 28(6):645-9. PubMed ID: 16945217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonistic autoantibodies to the α(1) -adrenergic receptor and the β(2) -adrenergic receptor in Alzheimer's and vascular dementia.
    Karczewski P; Hempel P; Kunze R; Bimmler M
    Scand J Immunol; 2012 May; 75(5):524-30. PubMed ID: 22260197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoemulsions for targeting the neurodegenerative diseases: Alzheimer's, Parkinson's and Prion's.
    Nirale P; Paul A; Yadav KS
    Life Sci; 2020 Mar; 245():117394. PubMed ID: 32017870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New pharmacologic aspects in the neurologic profile of propentofylline (Karsivan ad us. vet.)].
    Kapl D; Rudolphi KA
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 1998 Sep; 26(5):317-21. PubMed ID: 9931990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia.
    D'Arrigo JS
    Am J Alzheimers Dis Other Demen; 2020; 35():1533317520976761. PubMed ID: 33307726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology.
    Bennett S; Grant MM; Aldred S
    J Alzheimers Dis; 2009; 17(2):245-57. PubMed ID: 19221412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dementia. Outlook on current developments].
    Jonker C
    Tijdschr Gerontol Geriatr; 1997 Aug; 28(4):163-71. PubMed ID: 9526785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatments for vascular dementia and Alzheimer's disease].
    Kitamura S
    Nihon Ika Daigaku Zasshi; 1999 Feb; 66(1):52-5. PubMed ID: 10097593
    [No Abstract]   [Full Text] [Related]  

  • 18. Interventions for heart disease and their effects on Alzheimer's disease.
    Wolozin B; Bednar MM
    Neurol Res; 2006 Sep; 28(6):630-6. PubMed ID: 16945215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical microinfarcts in Alzheimer's disease and subcortical vascular dementia.
    Okamoto Y; Ihara M; Fujita Y; Ito H; Takahashi R; Tomimoto H
    Neuroreport; 2009 Jul; 20(11):990-6. PubMed ID: 19483658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy.
    Weller RO; Cohen NR; Nicoll JA
    Panminerva Med; 2004 Dec; 46(4):239-51. PubMed ID: 15876980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.